InvestLog
← Back to Research← 返回研究
BSXEarnings ReleaseSource checkedAugust 3, 2026by InvestLog AI

BSX earnings release — EPS beat +3.0% · revenue beat +1.2%波士顿科学 (BSX) 财报发布 — EPS 高于预期+3.0% · 营收 高于预期+1.2%

Key Results

Boston Scientific Corporation (BSX) published results at 2026-07-30 16:05:00.

Actual vs Consensus

  • EPS: $0.86 vs $0.83 estimate, beat+3.0%.
  • Revenue: $5.4B vs $5.4B estimate, beat+1.2%.

    • Profitability and Cash Flow

  • Period: 2026 Q2 period ended 2026-06-30
  • Revenue: $5.4B; YoY: +4.6%
  • Gross profit: $3.8B; Gross margin: 70.7%
  • Operating income: $1.2B; Operating margin: 21.6%
  • Net income: $907M; GAAP diluted EPS: $0.61
  • Operating cash flow: $348M; Capex: $177M; Free cash flow: $171M
  • Cash: $1.5B; Total debt: $11.0B; Net debt: $9.5B

    • Official release: Penumbra, Inc. Reports Second Quarter 2026 Financial Results

    核心结果

    波士顿科学 (BSX) 已发布财报，发布时间：2026-07-30 16:05:00。

    实际值与市场预期

  • EPS：$0.86 vs $0.83 预期，高于预期+3.0%。
  • 营收：$5.4B vs $5.4B 预期，高于预期+1.2%。

    • 利润与现金流

  • 期间：2026 Q2 period ended 2026-06-30
  • 营收：$5.4B；同比：+4.6%
  • 毛利润：$3.8B；毛利率：70.7%
  • 经营利润：$1.2B；经营利润率：21.6%
  • 净利润：$907M；GAAP 稀释 EPS：$0.61
  • 经营现金流：$348M；资本开支：$177M；自由现金流：$171M
  • 现金：$1.5B；总债务：$11.0B；净债务：$9.5B

    • 官方公告：Penumbra, Inc. Reports Second Quarter 2026 Financial Results

    View BSX stock details ->查看 BSX 个股详情 ->

    This analysis was generated by InvestLog AI based on SEC filings, Form 4 insider transactions, Form 144 planned-sale notices, 13F institutional holdings, analyst ratings, and market data. It is for informational purposes only and does not constitute investment advice.这篇研究由 InvestLog AI 基于 SEC 披露、Form 4 内部人交易、Form 144 计划减持、13F 机构持仓、分析师评级和市场数据生成。内容仅供参考，不构成投资建议。